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Abstract We report the simultaneous presence of two phospho-
lipase A2 (PLA2) neurotoxins in the venom of Vipera aspis
aspis, the ¢rst such observation. One is monomeric and identical
to ammodytoxin B of Vipera ammodytes ammodytes. Its pres-
ence may result from gene £ux after interbreeding between
V. aspis aspis and V. ammodytes ammodytes. The second, a
novel heterodimer named vaspin, is very similar to vipoxin of
Vipera ammodytes meridionalis and to PLA2-I of Vipera aspis
zinnikeri. It may result from expression of preexisting genes,
the acidic subunit evolving from an ancestor common to ammo-
dytin I2 from V. ammodytes ammodytes, which we also found in
V. aspis aspis. ' 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Three venomous snakes are of public health signi¢cance in
Europe: Vipera aspis (Linne¤e, 1758), Vipera berus (Linne¤e,
1758) and Vipera ammodytes (Linne¤e, 1758). Envenomation
by the most widespread vipers found in France, V. aspis aspis
(Linne¤e, 1758) (Vaa) and V. berus berus (Linne¤e, 1758) (Vbb),
generally causes local symptoms (pain, edema, phlyctenosis)
associated in severe cases with systemic e¡ects (gastrointesti-
nal disorders and hypotension) [1]. In addition, neurological
symptoms (diplopia, paralysis) have been observed following
V. ammodytes or ‘V. aspis zinnikeri Kramer, 1958’ bites (Vaz)
[2].
The venoms of Vaa and Vbb are very similar in activity and
contain proteins acting on hemostasis, in£ammation and
blood pressure [3^7]. The venom of V. ammodytes species
di¡ers from those of Vaa and Vbb in that it contains neuro-
toxic phospholipases A2 (PLA2) which may be either mono-
meric or heterodimeric [8,9]. Monomeric PLA2s have been
demonstrated in the venom of V. ammodytes ammodytes (Lin-
ne¤e, 1758) (Vamam) : they consist of three isoforms, namely
ammodytoxin A, B and C, and block acetylcholine release in
neuromuscular junction. The heterodimeric PLA2 vipoxin
from V. ammodytes is a postsynaptic neurotoxin. It consists
of a presynaptic neurotoxic basic protein with PLA2 activity
and a non-toxic, non-enzymatic, acidic protein that protects
the basic subunit from degradation and modi¢es its pharma-
cological activity. Its subspecies origin is unclear. Recent pa-
pers suggested that it is a speci¢c neurotoxin from V. ammo-
dytes meridionalis Boulenger, 1903 [10,11] (Vamme) whereas
previous studies described its isolation from the venom of
Vamam snakes [12^14]. A similar heterodimeric neurotoxin
has also been found in Vaz venom [15,16]. The neurotoxins
found in the European viper subspecies and their sites of
action are listed in Table 1.
Between 1992 and 2001, the Marseille Poison Center ob-
served 11 cases of envenomation after Vaa bites in Southeast
France (departments of Alpes-Maritimes and Alpes-de-Haute-
Provence) involving unexpected neurological signs in addition
to the more usual symptoms that were only mild in intensity
[17,18]. The viper responsible for one of these ‘neurotoxic’
envenomations was captured alive and was classi¢ed as Vaa
on the basis of its morphology. The composition pattern of its
venom as assessed by polyacrylamide gel electrophoresis
(PAGE) was similar to that of Vaz and di¡erent from that
of the nominotypic Vaa [18]. This was surprising as recent
herpetological data indicate that Vaz is only found in South-
west France [19]. Spread of the Vaz population is unlikely
because there have been no neurotoxic envenomations be-
tween Montpellier (He¤rault) and Nice (Alpes-Maritimes).
The numerous bites associated with neurological signs in
this region suggest the appearance of a new population of
snakes. Intraspeci¢c variations in snake venom composition
have often been described without associated di¡erences in
morphology between individuals [20]. In the Vipera genus,
this phenomenon was ¢rst found in Southeast Europe (Bul-
garia), then in Southwest (France) and recently in Asia (Ta|«-
wan) [21]. The causes of the changes in venom composition
within a species or a subspecies are still unclear [22]. The
neurotoxic components of the venom of vipers are all mem-
bers of the group IIA PLA2 family. PLA2 genes undergo
accelerated molecular evolution [23], so we investigated
whether the variability of symptoms is associated with
changes in venom composition.
Here, we report for the ¢rst time the presence of two neuro-
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toxins in the venom of Vaa : ammodytoxin B and a novel
neurotoxin, vaspin, which is a non-covalent complex of one
acidic and one basic group IIA PLA2, analogous to vipoxin
and PLA2-I. Molecular modeling and structural analysis of
vaspin suggest that this toxin is responsible for neurological
symptoms, possibly by acting at postsynaptic neuromuscular
junctions. The acidic subunit of vaspin appears to share a
common ancestor with ammodytin I2 from Vamam.
2. Materials and methods
2.1. Materials
Total RNA was extracted in deionized water and 0.001% DEPC
(ICN Biomedicals, USA), ethanol absolute from Merck (Darmstadt,
Germany), propan-2-ol from Prolabo (Fontenay sous bois, France)
and chloroform from Carlo Erba Reagenti (Val de Reuil, France).
RT-PCR was performed with the Ready To Go1 You Prime First-
Strand Beads product from Amersham Pharmacia Biotech (Piscat-
away, NJ, USA). PCR nucleotide mix from Promega (Madison,
WA, USA) and Genset oligo primers (Paris, France) were used.
Taq DNA polymerase and 10U bu¡er were purchased from Amer-
sham Pharmacia Biotech. The equipment used included an Eppendorf
mastercycler gradient machine for PCR, a Biola¢tte table for shaking
and an Eppendorf 5810R for centrifugation.
The study is based on the extraction of seven Vaa venom glands.
Three of these snakes were captured in the department of the Puy-de-
Do“me, where only classical cases of envenomations were reported,
and used as controls. The four others were captured in the Alpes-
Maritimes and the Alpes-de-Haute-Provence departments. One of the
snakes was captured just after a bite in the Alpes-Maritimes and was
responsible for neurological symptoms as described by de Haro et al.
[17].
2.2. Methods
Snakes were identi¢ed by use of classical keys of determination
(e.g., number of ventral and susocular plates, scale ranges between
the labial plates and the eye). The vipers were conserved at 380‡C
until total RNA was extracted from the venom glands
2.2.1. Total RNA extraction. Total RNA was prepared from the
venom glands as described by Chomczynski and Sacchi, [24] using
Trizol reagent (Invitrogen BV, Leek, The Netherlands).
2.2.2. RT-PCR. Single-stranded cDNAs were prepared from total
RNA (2 Wg) using the First Stranded reaction kit (Amersham Bio-
sciences, USA) and random hexamers (600 ng/ml). The forward prim-
er: 5P-CAGAGGGAGCCTGGAGGTGCTTCTGGACCC-3P and the
reverse primer: 5P-TCAGTATTGCATTCAGAATAATAGAG-
TAAC-3P were used to perform 30 cycles of PCR with 30 s of dena-
turation at 94‡C, 30 s of annealing at 55‡C and 1 min extension at
72‡C.
2.2.3. Ligation and molecular cloning. The PCR products were
ligated into the PCR 2.1 vector (Invitrogen) using the deoxythymi-
dine-tailed method. Constructs with inserts were selected by PCR,
using M13 vector primers.
2.2.4. Plasmidic DNA extraction. Standard techniques were used
for plasmid extraction from Escherichia coli [25].
2.2.5. DNA sequencing. DNA sequencing was performed auto-
matically by the Genopole, a technical platform in Institut Pasteur
of Paris.
2.2.6. Sequence analysis. Single site mutations were veri¢ed on
chromatograms before submitting the nucleotide and protein sequen-
ces to gene and protein databanks using Fasta and Blastn softwares.
ClustalW (version 3.0) was used for alignments and Mac Molly soft-
ware for translation and prediction of isoelectric points.
2.2.7. Molecular modeling. We assessed conformational and ener-
getic consequences of the amino acid replacements using the high-
resolution crystal structure of the non-covalent vipoxin complex
(PDB code 1JLT, 1.4 AW resolution) as the template protein for mod-
eling vaspin. Internal energy of the vaspin model was minimized fol-
lowed by a 10 ns molecular dynamics trajectory in a continuum sol-
vent with a dielectric function of 4r. Visualization and computations
were performed using a SGI graphic station and the insight II soft-
ware (Accelrys, San Diego, CA, USA).
3. Results
PLA2 primers corresponding to a non-coding region of the
PLA2 gene were used to amplify a 570 bp DNA fragment
from the total RNA. For each snake, 96 clones from two
independent PCR experiments were sequenced in forward
and reverse sense and the results were consistent. ClustalW
identi¢ed ¢ve groups of DNA encoding PLA2 sequences for
which all members were identical. Two of these ¢ve groups
were present in all Vaa snake glands (data not shown) where-
as three of them were identi¢ed only in the glands of the
vipers captured in southeastern France. They were very sim-
ilar to neurotoxic PLA2. Group 1 was 100% identical to the
Vamam ammodytoxin B [21] and was thus an active neuro-
toxin, group 2, 95% identical to the Daboia russelli siamensis
(formerly Vipera russelli formosensis) RV7; and group 3,
95.4% identical to the RV4 of the same species (Fig. 1) [21].
The theoretical pI of the group 2 PLA2 was 4.2 and that of
group 3, 8.7. The cDNAs for group 1, 2 and 3 PLA2 each
encode a signal peptide of 16 amino acid residues followed by
a peptide chain of 122 residues. The deduced proteins of the
group 2 (acidic) and 3 (basic) sequences, present high degrees
of sequence identity to three distinct heterodimeric neurotox-
ins (see Fig. 2). They are very similar to the acidic and basic
subunits respectively of PLA2-I (98.75%), vipoxin (98.75%)
and RV4/RV7 (92.00%) complexes [11,15,26,27]. The group
2 subunit is identical to the acidic subunit of PLA2-I from
Vaz, 98.3% identical to the vipoxin inhibitor (PDB code 1JLT,
the most recently described vipoxin isoform sequence of the
PLA2, from Vamme venom) and only 92.7% to RV7. In com-
mon with the vipoxin inhibitor, His48, essential for catalysis,
is replaced by a Gln [28], implying that the group 2 subunit
lacks enzymatic activity. RV7 di¡ers from the others by the
conservation of the catalytic activity (His48) and eight other
amino acid di¡erences. The acidic subunits of V. aspis o¡-
spring di¡er from those of V. ammodytes and Daboia by a
Thr70Met substitution. The group 3 protein is very similar to
Table 1
PLA2 neurotoxins from European viper venom
Viper subspecies Neurotoxin(s) Activity References
Vaa none ^ ^
Vaz PLA2-I postsynaptic heterodimer associating a presynaptic basic subunit and a
PLA2-like subunit
[15,16]
Vamam ammodytoxin A, B, C presynaptic monomer [8]
vipoxin postsynaptic heterodimer associating a presynaptic basic subunit and a
PLA2-like subunit
[9,12,13]
Vamme vipoxin postsynaptic heterodimer associating a presynaptic basic subunit and a
PLA2-like subunit
[10,11]
Vbb none ^ ^
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the vipoxin (basic subunit), with a single Lys118Arg substitu-
tion: it presents 99.2% identity and is thus closer to vipoxin
than to PLA2-I in which there are Gln79Lys, Leu88Gln and
Lys120Leu substitutions. It is thus likely that the group 2 and
group 3 proteins are acidic and basic subunits forming a het-
erodimeric PLA2, which we call vaspin.
The small amount of venom (10^20 Wl) available did not
allow us to purify vaspin either for crystallization or for bio-
logical tests. However, the high degree of sequence identity
(98.75%) with vipoxin allowed us to use the crystal structure
of vipoxin as a template to assess the consequences of the
amino acid substitutions on the stability, structure and bio-
logical activity of the complex. Fig. 3 shows a molecular
model of vaspin, highlighting the interface between the sub-
units.
Two amino acid substitutions exist in the acidic subunit of
vaspin (Ala35Gly and Thr70Met). Gly35 is not exposed to the
solvent and presents no steric hindrance. The Ca2þ binding
loop that is located immediately upstream does not appear to
be functionally or structurally altered. The Thr70Met replace-
ment does not alter the electrostatic charge. Although the
aliphatic side chain of Met70 is twice as long as that of
Thr, it is not responsible for steric hindrance. A cavity oppo-
site position 70, formed by residues Tyr28, Phe46, Asp49 and
the Cys50^Cys133 disul¢de bond of the basic subunit, is large
enough to accommodate this side chain without atomic con-
tacts. The new side chain would displace between one and
three of the interfacial water molecules in 1JLT into the
bulk solvent. This leads to the loss of one or two hydrogen
bonds. This destabilizing enthalpic e¡ect is countered by the
Fig. 1. Alignment of the cDNA nucleotide sequences of the group 2 and 3 Vaa PLA2 with RV7 and RV4. The primers used for the PCR am-
pli¢cation of the cDNA are underlined. Mutations are shadowed.
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positive entropy di¡erence resulting from the release of the
interface water molecules into the bulk solvent. In view of
this entropy^enthalpy compensation e¡ect of Thr70Met in
the acidic subunit, we predict that the stability of the vaspin
complex is similar to that of the vipoxin complex. The Met70
side chain moves between 4.1 and 7.4 AW away from that of the
acidic subunit Asp49. Finally, as in the structure by Banuma-
thi et al. [10], amino acids 35 and 70 are not involved in the
interaction with the basic subunit.
Position 118 in the basic subunit is exposed to the solvent.
As in the X-ray structure [10], it is not involved in the inter-
action with the acidic subunit [10] and has no e¡ects on the
conformation of the enzyme or of the complex. Furthermore,
this substitution is not located within the regions involved in
the neurotoxicity of postsynaptic neurotoxins like vipoxin, i.e.
residues 6, 12, 76^81 (the L-wing) and 119^125 [26]. More-
over, this substitution is also found in the basic subunit of
Vaz PLA2-I (Lys120) without loss of neurotoxicity.
The energy minimization and molecular dynamics simula-
tions result in a stable complex. The RMSDs of CK distances
between the model and the template structures over the sim-
ulation trajectory are of about 2 AW . In conclusion, the ob-
served substitutions seem to have no substantial e¡ect on
the stability of the complex and cause only limited structural
di¡erence. It is thus likely that vaspin is an active neurotoxin
and that it contributes to the manifestation of neurological
symptoms.
4. Discussion
We report the ¢rst description of two neurotoxins in the
venom of Vaa snakes from two departments of Southeastern
France, following molecular cloning of the cDNA of venom
gland total mRNA. One is a monomeric PLA2, perfectly iden-
tical to ammodytoxin B found in the venom of Vamam, which
acts presynaptically at the neuromuscular junction [27]. The
other is a novel non-covalent PLA2 heterodimer, named vas-
pin. The signal peptides of the three PLA2 sequences contain
the expected ‘positive-hydrophobic-polar’ domains required
for secretion [29], and thus participation in the toxicity of
Fig. 2. Comparison of the predicted amino acid sequences for the acidic and basic subunits of the neurotoxin. Squares show the 16 residue
long signal peptide. The common numbering of PLA2s by Renetseder [34] is used. A dot indicates identical amino acid residue, and gaps intro-
duced to optimize the alignment are shown by dashes. Numbers in parentheses are percentages of sequence identity to the ¢rst sequence.
A: Alignment of acidic subunits of PLA2 neurotoxins from: Vaz (PLA2-I; gi: 1709547), Vamme (vipoxin inhibitor; gi : 16974941), D. russelli
siamensis (RV4; gi: 64453). B: Alignment of basic subunits of PLA2 neurotoxins from: Vaz (PLA2-I; gi: 1709548), Vamme (vipoxin;
gi: 16974940), D. russelli siamensis (RV7; gi : 64453).
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the venom. Vaspin is very similar to three known neurotoxic
complexes: the postsynaptic PLA2-I from Vaz, vipoxin from
Vamme and the presynaptic RV4/RV7 complex from D. rus-
selli siamensis. Blinov et al. (1979) have reported that the
vipoxin complex had a speci¢c e¡ect on the postsynaptic
membrane, decreasing its sensitivity to acetylcholine [30].
This is consistent with the inhibitory e¡ect of PLA2-I on the
contractile response to direct stimulation of mouse diaphragm
[31]. In view of the sequence and structural similarities, vaspin
must display a similar activity to vipoxin and PLA2-I, namely
postsynaptic blocking of the neuromuscular junction.
Since neurological symptoms following Vaa envenomations
had never been reported near Nice before 1992, the Vaa ven-
om composition must have changed around that date.
Although there is ambiguity on the occurrence of vipoxin in
ammodytes subspecies, toxicity studies with ammodytes ven-
oms after gel ¢ltration never found both the heterodimeric
and the monomeric neurotoxins in the same snake. The ap-
pearance in the same venom of these two neurotoxins prob-
ably results from two distinct mechanisms, which should be
considered separately.
Firstly, the presence of ammodytoxin B could be due to the
occasional expression of a preexisting Vaa gene under partic-
ular environmental or physiological conditions. Alternatively,
this gene could come from a nearby Italian population of
Vamam either by an expansion of the population or from
interbreeding between Vaa and Vamam (possibly following
accidental introduction of Vamam). Such hybrids can be pro-
duced in captivity and have been observed in Italy [32]. This is
consistent with the unexpected neurological symptoms ob-
served in Italy (between 1980 and 1984) after Vaa bites [33].
It should be noted that a perfect identity of the nucleotidic
sequences was observed between ammodytoxin B-encoding
mRNA of Vaa and Vamam. Since it is unlikely that preexist-
ing genes have evolved in two distinct o¡springs without de-
veloping any substitution, we therefore support the second
hypothesis.
Secondly, vaspin is as similar to vipoxin as to PLA2-I
(98.75% identity). Gene £ow for vaspin is unlikely because
of the geographical barriers that separate the populations in
which it is expressed from the aspis population near Nice.
Banumathi et al. [10] stated that the vipoxin inhibitor ‘is a
product of divergent evolution of the unstable PLA2’ to ‘sta-
bilize it and in this way preserve the pharmacological activity
and toxicity for a long period’. Our study suggests that this is
not the case. Indeed, neurotoxic heterodimers are likely to be
the product of the divergent evolution of a duplicated ances-
tral PLA2 gene. As these similar complexes are found in dif-
ferent populations, the gene must have duplicated and the
copies diverged before the separation of the aspis and ammo-
dytes groups. Thereafter the PLA2-encoding genes evolved to
produce these di¡erent complexes. The sequence di¡erences
between the two PLA2-subunits di¡er according to the spe-
cies. The two genes may thus have evolved independently until
the acquisition of the new function. On another hand, amino
acid sequence similarities between the acidic and basic sub-
units of each vaspin (63%), vipoxin (62%) and PLA2-I (65%)
are less than those between the acidic subunit of vaspin and
another PLA2, ammodytin I2 from Vamam (74%). Since we
detected the ammodytin I2 gene in the Vaa (sensus stricto)
genome (personal communication), the acidic subunits of the
three neurotoxins may share a common ancestor with ammo-
dytin I2. The appearance of the acidic subunits may thus not
be the result of a directed evolution but the product of ran-
Fig. 3. A point in the dynamics trajectory of vaspin, the neurotoxic non-covalent PLA2 heterodimer. The molecular model is derived from the
crystallographic structure of the vipoxin complex (PDB id: 1JLT). The acidic subunit is in magenta ribbon and the basic one in yellow. Re-
placed amino acids are colored in green. The solvent accessible surface of the amino acids that form a cavity in front of Met70 is shadowed in
red.
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dom evolution conferring an advantage and with selective
acting on the two subunits. The chaperone function of the
acidic subunit may be an acquired function allowing postsyn-
aptic membranes of the neuromuscular junction to be tar-
geted. Accordingly, the genes for the two subunits of vaspin
should be present in the V. aspis genome. It is possible that
the genes are normally expressed at a low level or are silent
and that their expression is increased by stress. In such a case,
we should attempt to observe other spots of vaspin expression
in some Vaa populations or expression of similar complexes.
In conclusion, we demonstrate the recent appearance of a
new geographical race of Vaa in southeast France, which ex-
presses both monomeric and heterodimeric neurotoxins in its
venom. These neurotoxins result from two distinct events.
One is that the ammodytoxin B gene was acquired from Va-
mam either by gene £ow from Italy after interbreeding with
Vaa or by clandestine introduction in Southeast France. The
other is that vaspin results from the occasional expression of
preexisting Vaa genes. The acidic subunit of the complex may
share a common ancestor with the ammodytin I2 gene, which
may have duplicated before the separation of aspis and am-
modytes o¡spring. Phylogenetic studies of viperid PLA2 and
genomic analysis of Vaa snakes are underway to further elu-
cidate this issue.
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